Low Incidence Rate of Opportunistic and Viral Infections During Imatinib Treatment in Chronic Myeloid Leukemia Patients in Early and Late Chronic Phase.

BACKGROUND: Imatinib has become first line therapy in chronic myeloid leukemia patients. Little is known about the infective consequences during the treatment with this drug in large series of chronic phase patients. MATERIAL AND METHODS: From January 2001 to September 2006 we treated with imatinib...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Breccia, Massimo, Girmenia, Corrado, Latagliata, Roberto, Loglisci, Giuseppina, Santopietro, Michelina, Federico, Vincenzo, Petrucci, Luigi, Serrao, Alessandra, Salaroli, Adriano, Alimena., Giuliana
Format: Artigo
Sprache:Inglês
Veröffentlicht: Università Cattolica del Sacro Cuore 2011
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3113277/
https://ncbi.nlm.nih.gov/pubmed/21713076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2011.021
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge